Sakura Bio
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.sakurabio.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
About Sakura Bio
Sakura Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sakura Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sakura Bio has new funding data
Earning: See what the market has to say on Sakura Bio recently announced quarterly report
Sakura Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sakura Bio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sakura Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sakura Bio launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sakura Bio
Check out if Sakura Bio is spiking on competitors!
Recommended Actions
Find VP level buyers at Sakura Bio
Find more new buyers
Company Profile Activity
Activity Insights
Sakura Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sakura Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sakura Bio.
Sakura Bio Tech Stack
A closer look at the technologies used by Sakura Bio
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Sakura Bio
Sakura Bio is a start-up biotech company focused on developing off-the-shelf, allogeneic T-cell therapies to combat cancer. Their lead product, Skill therapy, features a unique T-cell population that exhibits enhanced anti-tumor activity without harming healthy tissue. The company aims to pioneer the future of cancer treatment by creating effective... Read More
